Value of a complete or partial remission in severe lupus nephritis

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 1, 2008, Pages 46-53

  Chen, Yiann E ^a   Korbert, Stephen M ^a   Katz, Robert S ^a   Schwartz, Melvin M ^a   Lewis, Edmund J ^a,b   Roberts, J L ^b   Schwartz, M M ^a,b   Rodby, R A ^b   Corwin, H L ^b   Lachin, J M ^c   Lan, S P ^c   Cleary, P ^c   Bernstein, J ^c,d   Shapiro, H ^d   Rosenberg, B F ^d   Pohl, M A ^e   Clough, J ^e   Gephardt, G ^e   Berl, T ^f   Levin, N ^g   Hunsicker, L G ^h   Bonsib, S ^h   Simon, N ⁱ   Friederici, H ⁱ   del Greco, F ^j   Carone, F A ^j   Hebert, L ^k   Sharma, H M ^k   Nielson, E ^l   Tomazewski, J ^l   Levey, A ^m   Ucci, A ^m   Lemann, J ⁿ   Blumenthal, S S ⁿ   Garancis, J ⁿ   Shapiro, K ^o   Chander, P ^o   Whittier, F ^a   Graves, J W ^a   Bathon, J ^a   Riley, P ^a   Hill, G H ^p   Holley, K ^q   more..

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f HENRY FORD HOSPITAL   (United States)

^g UNIVERSITY OF IOWA   (United States)

^h EVANSTON HOSPITAL   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

^j OHIO STATE UNIVERSITY   (United States)

^k UNIVERSITY OF PENNSYLVANIA   (United States)

^l TUFTS MEDICAL CENTER   (United States)

^m MEDICAL COLLEGE OF WISCONSIN   (United States)

ⁿ NEW YORK MEDICAL COLLEGE   (United States)

^o WEST VIRGINIA UNIVERSITY   (United States)

^p DEPARTMENT OF PATHOLOGY   (United States)

^q MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOPSY; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; KIDNEY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PLASMAPHERESIS; PROGNOSIS; PROSPECTIVE STUDY; REMISSION; SURVIVAL; TREATMENT OUTCOME;

ADULT; BIOPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PLASMAPHERESIS; PROGNOSIS; PROSPECTIVE STUDIES; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 38749151010     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03280807     Document Type: Article

References (38)

1. Boumpas DT, Balow JE: Outcome criteria for lupus nephritis trials: A critical overview. Lupus 7: 622-629, 1998
2. Fraenkel L, MacKenzie T, Joseph L, Kashgarian M, Hayslett JP, Esdaile JM: Response to treatment as a predictor of longterm outcome in patients with lupus nephritis. J Rheumatol 21: 2052-2057, 1994
3. Appel GB, Cohen DL Pirani CL, Meltzer JI, Estes D: Long-term follow-up of patients with lupus nephritis: A study based on the classification of the World Health Organization. Am J Med 83: 877-885, 1987
4. Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon GE, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gul A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R: Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum 50: 3934-3940, 2004
5. Cortes-Hernandez J, Ordi-Ros J, Labrador M, Segarra A, Tovar JL, Balada E, Vilardell-Tarres M: Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone. Lupus 12: 287-296, 2003
6. Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD, for the Lupus Nephritis Collaborative Study Group: Factors predictive of outcome in severe lupus nephritis. Am J Kidney Dis 35: 904-914, 2000
7. Mok CC, Ho CT, Chan KW, Lau CS, Wong RW: Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine. Arthritis Rheum 46: 1003-1013, 2002
8. Chan TM, Tse KC, Tang CS, Lai KN, Li FK: Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine. Lupus 14: 265-272, 2005
9. Illei GG, Takada K, Parkin D, Austin HA, Crane M, Yarboro CH, Vaughan EM, Kuroiwa T, Danning CL, Pando J, Steinberg AD, Gourley MF, Klippel JH, Balow JE, Boumpas DT: Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: Long-term followup of a cohort of 145 patients participating in randomized controlled studies. Arthritis Rheum 46: 995-1002, 2002
10. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC: Idiopathic membranous nephropathy: Definition and relevance of a partial remission. Kidney Int 66: 1199-1205, 2004
11. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC: Focal and segmental glomerulosclerosis: Definition and relevance of a partial remission. J Am Soc Nephrol 16: 1061-1068, 2005
12. Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM, Lupus Nephritis Collaborative Study Group: A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 326:1373-1379, 1992
13. Clough JD, Lewis EJ, Lachdn JM, Lupus Nephritis Collaborative Study Group: Treatment protocols of the lupus nephritis collaborative study of plasmapheresis in severe lupus nephritis. Prog Clin Biol Res 337: 301-307, 1990
14. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277, 1982
15. Churg J, Sobin LH: Renal Disease: Classification and Atlas of Glomerular Disease, Tokyo, Igaku-Shoin, 1982
16. Schwartz MM, Lan SP, Bonsib SM, Gephardt GN, Sharma HM, Lupus Nephritis Collaborative Study Group: Clinical outcome of three discrete histologic patterns of injury in severe lupus glomerulonephritis. Am J Kidney Dis 13: 273-283, 1989
17. Schwartz MM, Bernstein J, Hill GS, Holley KE, Phillips EA, Lupus Nephritis Collaborative Study Group: Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Kidney Int 36: 891-896, 1989
18. Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel 1H, Decker JL, Balow JE: Prognostic factors in lupus nephritis: Contribution of renal histologic data. Am J Med 75: 382-391, 1983
19. Schwartz MM, Lan SP, Bernstein J, Hill GS, Holley KE, Lewis EJ, Lupus Nephritis Collaborative Study Group: Role of pathology indices in the management of severe lupus glomerulonephritis. Kidney Int 42: 743-748, 1992
20. Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J: Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 59: 2156-2163, 2001
21. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M: The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15: 241-250, 2004
22. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M: The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65: 521-530, 2004
23. Roberts JL, Lewis EJ: Identification of antinative DNA antibodies in cryoglobulinemic states. Am J Med 65: 437-455, 1978
24. Harley JB, Sestak AL, Willis LG, Fu SM, Hansen JA, Reichlin M: A model for disease heterogeneity in systemic lupus erythematosus. Arthritis Rheum 32: 826-836, 1989
25. Reichlin M: Measurements of antibodies to Sm and nRNP by ELISA: Clinical and serological correlations. In: Mixed Connective Tissue Disease and Autoantibodies, edited by Kasukawa R, Sharp GC, Amsterdam, Elsevier, 1987, pp 85-96
26. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data, New York, John Wiley, 1980
27. Moroni G, Quaglini S, Maccario M, Banfi G, Ponticelli C: "Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int 50: 2047-2053, 1996
28. Ciruelo E, de la. Cruz J, Lopez I, Gomez-Reino JJ: Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide. Arthritis Rheum 39: 2028-2034, 1996
29. Cross J, Dwomoa A, Andrews P, Burns A, Gordon C, Main J, Mathieson P, O'Donoghue D, Jayne D: Mycophenolate mofetil for remission induction in severe lupus nephritis. Nephron Clin Pract 100: c92-c100, 2005
30. Barber CE, Geldenhuys L, Hanly JG: Sustained remission of lupus nephritis. Lupus 15: 94-101, 2006
31. Gourley MF, Austin HA 3rd, Scott D, Yarboro CH, Vaughan EM, Muir J, Boumpas DT, Klippel JH, Balow JE, Steinberg AD: Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis: A randomized, controlled trial. Ann Intern Med 125: 549-557, 1996
32. Ioannidis JP, Boki KA, Katsorida ME, Drosos AA, Skopouli FN, Boletis JN, Moutsopoulos HM: Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide. Kidney Int 57: 258-264, 2000
33. Chan TM, Tse KC, Tang CS, Mok MY, Li FK: Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol 16: 1076-1084, 2005
34. Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC: Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide. Am J Med 119: 355.e25-e33, 2006
35. Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, Appel GB: Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 353: 2219-2228, 2005
36. Mosca M, Neri R, Giannessi S, Pasquariello A, Puccini R, Bencivelli W, Bombardieri S: Therapy with pulse methylprednisolone and short course pulse cyclophosphamide for diffuse proliferative glomerulonephritis. Lupus 10: 253-257, 2001
37. Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL, Lau CS, Wong AK, Tong MK, Chan KW, Lai KN: Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 343: 1156-1162, 2000
38. Balow JE: Clinical presentation and monitoring of lupus nephritis. Lupus 14: 25-30, 2005